Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 360 entries
View as:

Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT00125424 Org: User:
Start: 07/31/05 End: 09/30/05 Due: 09/30/06

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00051025 Org: User:
Start: 05/31/00 End: 09/30/06 Due: 09/30/07

Evaluation of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of E2609 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01511783 Org: User:
Start: 12/31/11 End: 11/30/12 Due: 11/30/13

A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology

Phase: N/A Priority: Normal
NCT ID: NCT04764669 Org: User:
Start: 02/25/21 End: 01/27/22 Due: 01/27/23

Efficacy and Safety Study of E2007 in Migraine Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT00154063 Org: User:
Start: 01/31/05 End: 06/30/06 Due: 06/30/07

A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure

Phase: N/A Priority: Normal
NCT ID: NCT01309984 Org: User:
Start: 11/30/10 End: 10/31/12 Due: 10/31/13

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01126749 Org: User:
Start: 04/16/10 End: 07/20/16 Due: 07/20/17

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

Phase: N/A Priority: Normal
NCT ID: NCT02085967 Org: User:
Start: 02/28/14 End: 06/30/14 Due: 06/30/15

Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers

Phase: N/A Priority: Normal
NCT ID: NCT00403520 Org: User:
Start: 11/30/06 End: 08/31/10 Due: 08/31/11

Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

Phase: N/A Priority: Normal
NCT ID: NCT03517449 Org: User:
Start: 06/11/18 End: 02/26/25 Due: 02/26/26

Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2)

Phase: N/A Priority: Normal
NCT ID: NCT02952820 Org: User:
Start: 11/15/16 End: 01/08/19 Due: 01/08/20

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01347645 Org: User:
Start: 09/30/11 End: 06/22/15 Due: 06/22/16

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT01995838 Org: User:
Start: 11/13/13 End: 04/29/14 Due: 04/29/15

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01355783 Org: User:
Start: 03/31/11 End: 11/30/14 Due: 11/30/15

A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04154189 Org: User:
Start: 03/23/20 End: 08/17/23 Due: 08/17/24

A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix

Phase: N/A Priority: Normal
NCT ID: NCT00264732 Org: User:
Start: 07/31/05 End: 05/31/09 Due: 05/31/10

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01126736 Org: User:
Start: 06/10/10 End: 03/18/15 Due: 03/18/16

An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory

Phase: N/A Priority: Normal
NCT ID: NCT01240421 Org: User:
Start: 03/31/11 End: 11/30/14 Due: 11/30/15

The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations

Phase: N/A Priority: Normal
NCT ID: NCT00451633 Org: User:
Start: 03/31/07 End: - Due: -

Safety and Efficacy of APD356 in the Treatment of Obesity

Phase: N/A Priority: Normal
NCT ID: NCT00116740 Org: User:
Start: 06/30/05 End: 11/30/05 Due: 11/30/06

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04008797 Org: User:
Start: 07/11/19 End: 08/31/27 Due: 08/31/28

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

Phase: N/A Priority: Normal
NCT ID: NCT03441360 Org: User:
Start: 04/17/18 End: 01/21/22 Due: 01/21/23

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03245151 Org: User:
Start: 11/16/17 End: 09/30/22 Due: 09/30/23

Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02792829 Org: User:
Start: 08/31/14 End: 08/31/14 Due: 08/31/15

Neural Correlates In Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00477659 Org: User:
Start: 07/23/07 End: 08/15/08 Due: 08/15/09